U should get your reply from those clowns Directors whom take a good remunerations but minority shareholders are left with 3.5 sen price of Bornoil shares. No Dividend only seeing BOrnoil price sliding......Dont expect much on Next QR ....with Covid at the background.
Bornoil has always been a goreng stock. Look at the chart history. Its never about the fundemental or dividend. So if you ask me, I will buy when its low and not moving.
Bornoil is a company of Jack of all trades??? Nothing shines from them with decent Quarter Results?? Gold, Bio energy, Pizza and now construction (rm750K company). Except Limestones which help to cut loss. Shit where are the Golds???
Bornoil making huge gain in their gold trading. The 2nd quarter result is forecasted to be good n even better for the 3rd quarter. It's warrant price of 0.015 is a good entry price.
I read back last year Jun 2019 financial report, the recent sudden spike of shares prices, the only factor that can make the counter jump high is the gold factor. Gold price now almost touching US 2K“. The report read: “on a positive note, the division’s exploration team had yielded encouraging results on the gold exploration conducted at Bukit Ibam, Pahang with inferred reserves of 1.8 metric tonnes of gold. Initial findings covering an area of about 1.98 hectares out of a total of 187 hectares in the tenement showed that the indicated gold grade is about 1.08 grams of gold per metric ton with a total probable gold reserves of about 550 kilograms. The Management is evaluating all options available for optimal production arrangements to extract the gold ores which will contribute positively to the Group in the foreseeable future.”
The current shares spike will it becos of gold factor? High possibility! I guess!
Read carefully “ the gold reserves of about 550 kilograms. The Management is evaluating all options available for optimal production arrangements to extract the gold ores which will contribute positively to the Group in the foreseeable future.”
I don’t like to do any guess games or mislead people. It is black and white stated in the report. If this round the actual news going to be announced is the “ Gold” news. The price will spike like nobody business
Bornoil in Gold trading again?? That was history unless new development. ? They lost big previously so are they better now n learnt their lesson well!!! Stocks of gold, if any are not reflected in the BS. ! Prices of gold fluctuates greatly..by the time the MD gets their acts right to mine n sell Gold...the Price of gold may have retreated.
Our hope for price appreciation lies on the new limestone plant and I am quite optimistic about the future prospect given that the new plant is already at advance stage of completion and additional funding to commission the operation has been established via the private placement proceeds. Hope for the best !
Bornoil is a public listed company. it is stated in the report that 187 hectares gold mining projects in Bukit Ibam, Pahang is on its way of exploration and production It is clearly stated in 2019 reports. The Management has yet to announce the latest outcome of the projects. Bear in mind the major shareholder Hap Seng & Tan Sri Lau is not a small player in the market. They are reputable with proven records. I wouldn’t be surprised if there are sudden announcement on the progress of the gold mining, the counter will fly high. If you study Bornoil , it has its history of shares movement. Once move, it will go very fast. You don’t hv time to catch.
Why KPJ is next gem for post covid-19? Based on Fundamental analysis our current PE guideline is approx 57.14 (Based on 1.75% of BNM base rate) thus the actual price for KPJ should be RM2.71. Covid-19 only good for medical sector (more clearly is protective medical equipment “glove, mask, face shield and etc” and diagnosis instrument “thermo scanners, PCR tester and etc” For Malaysia top glove, harta, kossan and supermx all are the first round winners.
For the last stage of vaccination development, now is the time to look for the next gem but unfortunately our country is impossible to produce these vaccine. The only vaccine we can get is import and we hv 20+mil ppl need to be vaccinated. Early stage of vaccine must be very expensive and gov won’t sponsor. We only can get vaccinated through private hospital no matter for travel or job requirement or just stay safe. Based on 2019, KPJ recorded 2,629,878 outpatients @ net profit 226.7mil with 28 hospitals overall the state. If half of 20mil ppl go KPJ for vaccination so approx net profit can reach up to 1bil. And u need to know tat those vaccine isn’t 1 injection for lifetime (like seasonally flu vaccine) and must get it semi or annually. RM1k-2k per vaccine per yrs for everyone to stay safe is new normal of post covid-19. And it is long term investment value of KPJ.
There are 23 potential vaccines developed and 3 candidates already passed the clinical trial and go for final stage of testing. 1. Moderna vaccine enter the final stage of human trials for its COVID-19 vaccine on July 27. 2. Oxford-AstraZeneca Covid-19 vaccine show good immune responses without side effect. 3. Chinese-made vaccine from Sinovac Biotech at final stage of testing in Brazil.
PATHOLOGY SERVICES - LABLINK (M) SDN BHD provide laboratory/pathology services to the KPJ Group. It manages the pathology laboratories in KPJ’s network of hospitals. Lablink also conducts clinical tests for more than 100 non-KPJ institutions (including hospitals under the Ministry of Health and University Hospitals) as wellas general practitioners’ clinics across Malaysia. Lablink is the first lab in Malaysia to be certified with Bio-Safety Level 3 (BSL3) facilities which allows testing of highly infectious diseases (according to World Health Organization (WHO) standards). In Mar 2020, Lablink was one of the private laboratories listed by the Ministry of Health (MOH) to perform COVID-19 rRT-PCR (i.e. real-time reverse transcription polymerase chain reaction) by testing specimens received from hospitals: both from walk-in members of the public as well as hospital inpatients. Lablink recorded revenue of RM102.2 million in 2019. The KPJ group of Hospitals classified Covid 19 rRT-PCR test according to urgent (result within 24 hours) and routine (beyond 24 hours). The COVID-19 testing capacity has been ramped up and Lablink has been able to test and report about 1,500-3,000 samples in a day in May 2020. The total number of samples, as at the end of May 2020 was in excess of 70,000; of which the KPJ-Group of Hospitals Nationwide contributed to almost 75% of the tests while the balance was from non-KPJ hospitals and the Ministry of Health.
PHARMASERV ALLIANCES SDN BHD (PASB) is KPJ’s centralized wholesaler and distributor of pharmaceutical, medical disposables and other hospital related products. Its clients are the KPJ network of hospitals and companies, as well as external clients within the government sector and other healthcare sector players. PASB is able to achieve profitable growth and retain a competitive edge by transferring cost savings to customers. In 2019, its revenue increased to RM451.1 million.
Regardless of Covid 19 outbreak, KPJ remain resilient of its business model. The group switches over to ramp up testing services and can generate augur profit to offset any downturn during outbreak.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
BlackWhite
1,053 posts
Posted by BlackWhite > 2020-07-23 22:29 | Report Abuse
444444, like to know how pp can help the company simply it borrows more money and cause company value to becone pesos